NCT07117409 2025-09-11
RI-NIVO
Azienda USL Reggio Emilia - IRCCS
Terminated
Clinical Trials
20 trialsNCT05534789 2025-01-20
Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).
Pfizer
Terminated
NCT03140176 2024-05-10
OPTIMISE
Pfizer
Terminated
NCT01117779 2024-01-19
TRACE
Boston Scientific Corporation
Terminated
NCT03709771 2024-01-12
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
Vanderbilt University Medical Center
Terminated
NCT04106167 2023-09-21
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Terminated
NCT04147143 2022-12-23
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Terminated
NCT02071719 2020-11-20
Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients
Amsterdam UMC, location VUmc
Terminated
NCT00854022 2020-02-25
Genetic Susceptibility to Kidney Cancer
Baylor College of Medicine
Terminated
NCT01195649 2019-06-04
Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy
Bayer
Terminated
NCT02747173 2018-04-26
METHEOS
Spanish Oncology Genito-Urinary Group
Terminated
NCT00899860 2017-05-30
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
Wake Forest University Health Sciences
Terminated
NCT01326390 2016-07-01
Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
Stanford University
Terminated
NCT01507740 2015-04-29
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Medical University Innsbruck
Terminated
NCT00942058 2014-01-29
CA9CRM
Centre Hospitalier Universitaire de Saint Etienne
Terminated
NCT01063998 2013-11-08
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
Corewell Health East
Terminated
NCT00896467 2013-07-10
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
National Cancer Institute (NCI)
Terminated
NCT01073644 2013-07-04
Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
Pfizer
Terminated
NCT01466504 2013-04-15
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Dartmouth-Hitchcock Medical Center
Terminated
NCT01033981 2012-04-19
Cost Effectiveness Of Sunitinib In Central America And Caribbean
Pfizer
Terminated